{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:13:35Z","timestamp":1782008015394,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.radonc.2024.110334","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T18:24:41Z","timestamp":1716661481000},"page":"110334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: Results & reflections from the prematurely closed phase III HYBRID trial"],"prefix":"10.1016","volume":"197","author":[{"given":"Ming","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5863-6023","authenticated-orcid":false,"given":"Vivek","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3118-3396","authenticated-orcid":false,"given":"Xingyu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyue","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110334_b0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approach to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0010","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/ijc.21940","article-title":"Frequent EGFR mutations in brain metastases of lung adenocarcinoma","volume":"119","author":"Matsumoto","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.radonc.2024.110334_b0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1200\/JGO.2016.003392","article-title":"Epidermal growth factor receptor mutational status and brain metastaes in non-small cell lung cancer","volume":"3","author":"Bhatt","year":"2017","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.radonc.2024.110334_b0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11060-017-2590-x","article-title":"High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases","volume":"135","author":"Ge","year":"2017","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.radonc.2024.110334_b0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijrobp.2015.11.004","article-title":"A phase 2 trial of concurrent chemotherapy and proton therapy for stage III non-small cell lung cancer: results and reflections following early closure of a single-institution study","volume":"95","author":"Hoppe","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110334_b0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1200\/JCO.2011.40.1174","article-title":"Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer","volume":"31","author":"Welsh","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0035","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0040","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/annonc\/mdh276","article-title":"Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial","volume":"15","author":"Ceresoli","year":"2004","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.radonc.2024.110334_b9000","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/jamaoncol.2023.3350","article-title":"Personalized Radiation Therapy\u2014Spurning the \u201cOne Size Fits All\u201d Approach","volume":"9","author":"Verma","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110334_b0045","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1200\/JCO.2018.77.9363","article-title":"CNS efficacy of osimertinib in patients with T790M-positive advanced non-small cell lung cancer: data from a randomized phase III trial (AURA3)","volume":"36","author":"Wu","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0050","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.21037\/apm-20-605","article-title":"Osimertinib for EGFR-mutant lung cancer with central nervous system metastases: a meta-analysis and systematic review","volume":"9","author":"Wang","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.radonc.2024.110334_b0055","article-title":"Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study","volume":"4: vdab88","author":"Peled","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.radonc.2024.110334_b0060","doi-asserted-by":"crossref","first-page":"e201617","DOI":"10.1001\/jamanetworkopen.2020.1617","article-title":"Assessment of effectiveness and safety of osimertinib for patients with intracranial metastatic disease: a systematic review and meta-analysis","volume":"3","author":"Erickson","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.radonc.2024.110334_b0065","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.03.048","article-title":"Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone","volume":"68","author":"Aoyama","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110334_b0070","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"Soffietti","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.radonc.2024.110334_b0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2016.10.005","article-title":"Stereotactic radiotherapy of the tumor bed compared to whole brain radiotherapy after surgery of single brain metastasis: results from a randomized trial","volume":"121","author":"Kepka","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ctrv.2012.11.001","article-title":"A meta-analysis of the effects of chemotherapy on cognition in patients with cancer","volume":"39","author":"Hodgson","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.radonc.2024.110334_b0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.coc.0000143016.15783.5b","article-title":"Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients\u2019 perspective regarding complications","volume":"28","author":"Kondziolka","year":"2005","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0269216309105787","article-title":"What do patients with brain metastases from non-small cell lung cancer want from their treatment?","volume":"23","author":"Dorman","year":"2009","journal-title":"Palliat. Med."},{"key":"10.1016\/j.radonc.2024.110334_b0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11060-021-03714-w","article-title":"Management of multiple brain metastases: a patterns of care survey within the German society for radiation oncology","volume":"152","author":"Kraft","year":"2021","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.radonc.2024.110334_b0110","unstructured":"AstraZeneca. Tagrisso\u00ae (osimertinib) significantly improves progression-free survival in the phase III FLAURA trial for lung cancer. https:\/\/www.astrazeneca-us.com\/media\/press-releases\/2017\/tagrisso-osimertinib-significantly-improves-progression-free-survival-in-the-phase-iii-flaura-trial-for-lung-cancer-07272017.html#! Accessed June 29, 2023."},{"key":"10.1016\/j.radonc.2024.110334_b0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11060-017-2442-8","article-title":"The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies","volume":"133","author":"Kim","year":"2017","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.radonc.2024.110334_b0120","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3389\/fonc.2020.01246","article-title":"Impact of tyrosine kinase inhibitors (TKIs) combined with radiation therapy for the management of brain metastases from renal cell carcinoma","volume":"10","author":"Khan","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.radonc.2024.110334_b0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10555-020-09949-9","article-title":"Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and\/or immunotherapy) in brain metatases: a systematic review","volume":"40","author":"Borius","year":"2021","journal-title":"Cancer Metastasis Rev."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024006042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024006042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:20:39Z","timestamp":1777504839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024006042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"alternative-id":["S0167814024006042"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110334","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: Results & reflections from the prematurely closed phase III HYBRID trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110334"}}